3-(((2-(2-(2-((Rutaecarpin-3-yl)oxy)ethoxy)ethoxy)ethyl)amino)methyl)-4-(naphtha-1-yl)-1,2,5-oxadiazole-2-oxide

ID: ALA4461959

PubChem CID: 155528728

Max Phase: Preclinical

Molecular Formula: C37H34N6O6

Molecular Weight: 658.72

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=c1c2cc(OCCOCCOCCNCc3c(-c4cccc5ccccc45)no[n+]3[O-])ccc2nc2n1CCc1c-2[nH]c2ccccc12

Standard InChI:  InChI=1S/C37H34N6O6/c44-37-30-22-25(12-13-32(30)40-36-35-29(14-16-42(36)37)27-9-3-4-11-31(27)39-35)48-21-20-47-19-18-46-17-15-38-23-33-34(41-49-43(33)45)28-10-5-7-24-6-1-2-8-26(24)28/h1-13,22,38-39H,14-21,23H2

Standard InChI Key:  YKIYURNSEYXAOQ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 49 56  0  0  0  0  0  0  0  0999 V2000
   47.2503  -16.4967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   47.2494  -15.6795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.5407  -16.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.5412  -17.7206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   47.2499  -18.1293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.5378  -15.2713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   47.8560  -15.1346    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   47.5239  -14.3858    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   46.7092  -14.4704    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   46.1633  -13.8624    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.6266  -15.2854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.3346  -15.6944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0443  -15.2850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0415  -14.4623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.6277  -14.4659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.3343  -14.0588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.3350  -13.2479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9219  -14.0621    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.0436  -12.8409    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.9243  -13.2450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.6335  -12.8385    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.6361  -12.0256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9311  -11.6130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2177  -12.8386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2254  -12.0197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4365  -13.0843    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.9613  -12.4173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4486  -11.7623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1248  -11.0150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3140  -10.9214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8281  -11.5813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1546  -12.3260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.7526  -15.6924    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.4597  -15.2827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.1681  -15.6902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.8751  -15.2805    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.5835  -15.6880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.2905  -15.2783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.9989  -15.6858    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   43.7060  -15.2761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.4143  -15.6836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.1214  -15.2739    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   45.8297  -15.6813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   47.9555  -16.9005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   47.9559  -17.7123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   48.6580  -18.1161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   49.3602  -17.7092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   49.3559  -16.8943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   48.6532  -16.4942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  3  4  1  0
  4  5  2  0
  5 45  1  0
 44  1  1  0
  6  2  1  0
  2  7  2  0
  7  8  1  0
  8  9  1  0
  9  6  2  0
  9 10  1  0
 15 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 16  2  0
 15 16  1  0
 15 18  1  0
 16 17  1  0
 17 21  1  0
 20 18  2  0
 17 19  2  0
 20 21  1  0
 20 24  1  0
 21 22  1  0
 22 23  1  0
 23 25  1  0
 24 25  2  0
 25 28  1  0
 27 26  1  0
 26 24  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 27  1  0
 13 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 43  6  1  0
 44 45  1  0
 45 46  2  0
 46 47  1  0
 47 48  2  0
 48 49  1  0
 49 44  2  0
M  CHG  2   9   1  10  -1
M  END

Alternative Forms

  1. Parent:

    ALA4461959

    ---

Associated Targets(non-human)

Aorta (2975 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 658.72Molecular Weight (Monoisotopic): 658.2540AlogP: 4.74#Rotatable Bonds: 13
Polar Surface Area: 143.37Molecular Species: NEUTRALHBA: 10HBD: 2
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.44CX Basic pKa: 5.98CX LogP: 2.44CX LogD: 2.42
Aromatic Rings: 7Heavy Atoms: 49QED Weighted: 0.13Np Likeness Score: -0.48

References

1. Ma J, Chen L, Fan J, Cao W, Zeng G, Wang Y, Li Y, Zhou Y, Deng X..  (2019)  Dual-targeting Rutaecarpine-NO donor hybrids as novel anti-hypertensive agents by promoting release of CGRP.,  168  [PMID:30818175] [10.1016/j.ejmech.2019.02.037]

Source